Scarica l'app Stockscreener
27.24
10.39%
-3.16
Precedente Chiudi:
$30.40
Aprire:
$30.71
Volume 24 ore:
653.59K
Relative Volume:
0.74
Capitalizzazione di mercato:
$3.45B
Reddito:
-
Utile/perdita netta:
$-112.46M
Rapporto P/E:
-16.61
EPS:
-1.64
Flusso di cassa netto:
$-99.89M
1 W Prestazione:
-21.72%
1M Prestazione:
-33.56%
6M Prestazione:
+61.37%
1 anno Prestazione:
+44.57%
Intervallo 1D:
$25.40
$31.98
Intervallo di 1 settimana:
$25.40
$35.40
Portata 52W:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Nome
Vor Biopharma Inc
Settore
Industria
Telefono
617-655-6580
Indirizzo
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Confronta VOR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
27.24 | 192.56M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Iniziato | Wedbush | Outperform |
| 2022-04-27 | Iniziato | Goldman | Neutral |
| 2021-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-03 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-02 | Iniziato | Oppenheimer | Outperform |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-25 | Iniziato | B. Riley Securities | Buy |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-03-03 | Iniziato | Evercore ISI | Outperform |
| 2021-03-02 | Iniziato | Goldman | Sell |
| 2021-03-02 | Iniziato | Stifel | Buy |
Mostra tutto
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Vor Biopharma (NASDAQ:VOR) Trading Down 7.2%Here's What Happened - MarketBeat
Vor Biopharma (NYSE:VOR) Stock Price Down 8.6% After Insider Selling - MarketBeat
Momentum Shift: What is the PEG ratio of Vor Biopharma IncQuarterly Trade Report & Entry Point Confirmation Signals - khodrobank.com
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 14,240 Shares of Stock - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 447,278 Shares - MarketBeat
Risk Report: Is Vor Biopharma Inc. part of any ETF2025 Price Action Summary & Verified Swing Trading Watchlists - khodrobank.com
Reprogrammed Interchange Llc Sells 300,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma Inc. (NYSE:VOR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Vor Biopharma ten percent owner sells $688k in shares By Investing.com - Investing.com Nigeria
Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale - GuruFocus
Vor Biopharma trading halted on Thursday, news pending (VOR:NASDAQ) - Seeking Alpha
Vor Biopharma ten percent owner sells $688k in shares - Investing.com
Gains Report: Is Vor Biopharma Inc stock overvalued or fairly pricedWeekly Trend Report & AI Driven Price Predictions - khodrobank.com
Vor Biopharma (NASDAQ:VOR) Rating Increased to Hold at Zacks Research - MarketBeat
Vor Bio Announces Oral Presentation of 48-Week China Phase - GlobeNewswire
Vor Biopharma announces 1-for-20 reverse stock split effective Thursday - Investing.com India
Weekly Recap: How cyclical is Vor Biopharma Inc.’s revenue stream2025 Market Outlook & High Win Rate Trade Tips - khodrobank.com
CEO Moves: Can Vor Biopharma Inc keep up with sector leadersJuly 2025 Highlights & Daily Market Momentum Tracking - خودرو بانک
Vor Biopharma Announces 1-for-20 Reverse Stock Split - TipRanks
Vor Biopharma files for 1-for-20 reverse stock splitSEC filing - MarketScreener
Vor Biopharma (NYSE:VOR) Major Shareholder Sells $656,000.00 in Stock - MarketBeat
Aug Opening: Can Vor Biopharma Inc. stock outperform in a bear marketMarket Sentiment Report & Verified Short-Term Plans - khodrobank.com
Market Review: Can Vor Biopharma Inc. grow without external fundingWeekly Risk Summary & Weekly Setup with ROI Potential - khodrobank.com
Reprogrammed Interchange Llc Sells 449,226 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Sells $637,000.00 in Stock - MarketBeat
Vor biopharma ten percent owner sells $1.7m in stock By Investing.com - Investing.com South Africa
Vor biopharma ten percent owner sells $1.7m in stock - Investing.com
Technical Analysis: Can Vor Biopharma Inc. stock outperform in a bear marketJuly 2025 Weekly Recap & Daily Stock Trend Reports - khodrobank.com
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 464,421 Shares - MarketBeat
Relative strength of Vor Biopharma Inc. in sector analysisTrade Exit Summary & Consistent Growth Stock Picks - newser.com
Vor Biopharma Inc. recovery potential after sell offWeekly Profit Recap & Verified Momentum Stock Watchlist - newser.com
Using fundamentals and technicals on Vor Biopharma Inc.Chart Signals & Entry Point Confirmation Alerts - newser.com
What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - newser.com
What to expect from Vor Biopharma Inc. in the next 30 days2025 Market Overview & Comprehensive Market Scan Insights - newser.com
How to interpret RSI for Vor Biopharma Inc. stockTrade Performance Summary & Growth Focused Entry Point Reports - newser.com
Will Vor Biopharma Inc. rebound enough to break evenWeekly Trade Recap & High Return Trade Guides - newser.com
Can momentum traders help lift Vor Biopharma Inc.Market Volume Report & High Win Rate Trade Tips - newser.com
Vor Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum - GlobeNewswire
Clinical-Stage Biotech Vor Bio to Showcase Autoimmune Disease Pipeline at Stifel 2025 Virtual Forum - Stock Titan
Hedge Fund and Insider Trading News: Ray Dalio, Warren Buffett, Bill Ackman, Point72 Asset Management, Brevan Howard, Broadcom Inc (AVGO), Vor Biopharma Inc (VOR), and More - Insider Monkey
We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully - Sahm
139,600 Shares in Vor Biopharma Inc. $VOR Acquired by OMERS ADMINISTRATION Corp - MarketBeat
Vor Biopharma (VOR) 10% owners sell $2.46 million in stock By Investing.com - Investing.com Canada
Vor Biopharma Inc Azioni (VOR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Vor Biopharma Inc Azioni (VOR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | 10% Owner |
Sep 15 '25 |
Sale |
1.64 |
400,000 |
656,320 |
33,228,487 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 12 '25 |
Sale |
1.75 |
300,000 |
526,230 |
33,628,487 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 11 '25 |
Sale |
1.83 |
284,805 |
521,421 |
33,928,487 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 08 '25 |
Sale |
1.99 |
464,421 |
924,058 |
35,012,518 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 09 '25 |
Sale |
2.00 |
449,226 |
898,632 |
34,563,292 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 10 '25 |
Sale |
1.82 |
350,000 |
635,285 |
34,213,292 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 03 '25 |
Sale |
2.00 |
554,612 |
1,107,061 |
36,329,955 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 04 '25 |
Sale |
1.93 |
453,016 |
873,641 |
35,876,939 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 05 '25 |
Sale |
1.97 |
400,000 |
787,280 |
35,476,939 |
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):